Long-acting analog insulin doesn't up AMI risk in T2DM
(HealthDay)—For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs versus other basal insulin therapies, according to a study published ...
Aug 20, 2015
0
7